InvestorsObserver is giving GW Pharmaceuticals PLC- ADR (GWPH) an Analyst Rating Rank of 79, meaning GWPH is ranked higher by analysts than 79% of stocks. The average projection by analysts for GWPH is $180.615 over the next 12 months and analyst’s classify the stock as a Strong Buy
Why are Analyst Ratings Important?
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
Investors Observer takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With GW Pharmaceuticals PLC- ADR Stock Today?
GW Pharmaceuticals PLC- ADR (GWPH) stock has fallen -0.26% while the S&P 500 has gained 1.48% as of 3:05 PM on Thursday, Jul 2. GWPH has fallen -$0.32 from the previous closing price of $126.19 on volume of 173,859 shares. Over the past year the S&P 500 is higher by 5.55% while GWPH has fallen -28.39%. GWPH earned $1.03 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 121.91.